Invenomic Institutional (BIVIX) Stock Price & Analysis
Invenomic Institutional (BIVIX) closed at USD 20.27 on Friday, October 23, 2026, down 0.69% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 20.27; the Oct 23, 2026 session ranged USD 20.27–20.27 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 13.8–20.41 (NAS). Source: Nexqual, retrieved October 24, 2026 at 09:28 UTC.
Also available as compact Markdown for AI agents: nexqual.com/BIVIX.md
Key facts (BIVIX)
- Total return with dividends: 1Y +23.1% vs S&P 500 +13.4%; 5Y +119.8% vs S&P 500 +76.9%.
Total return (dividends reinvested) (BIVIX)
| 1Y (from 2025-10-24) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +23.1% | +119.8% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +23.2% | +17.1% |
| Volatility (annualized) | 35.2% | 18.3% |
| Max drawdown | -26.9% (Mar 2026→Jun 2026) | -24.6% (Mar 2026→Jun 2026) |
Key Statistics (as of October 24, 2026 at 09:28 UTC)
| Price | USD 20.27 |
|---|---|
| Change | ▼ 0.69% (down) |
| Previous Close | USD 20.27 |
| Open | USD 20.27 |
| Day Range | USD 20.27 – 20.27 |
| 52-Week Range | USD 13.8 – 20.41 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (BIVIX)
Nexqual's technical model rates BIVIX "BUY" based on 5 bullish and 2 bearish signals across 127 daily candles, as of October 24, 2026 at 09:28 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 71.19 (overbought) |
| vs SMA50 | Above (USD 18.22) |
| MACD | 0.6 (positive) |
Financial Health Score (BIVIX)
Nexqual rates Invenomic Institutional's overall financial health "Mixed" across five dimensions, as of October 24, 2026 at 09:28 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BIVRX | Invenomic Fund Investor Class | USD 19.83 | ▲ 0% |
| BIVSX | Invenomic Fund Super Institutio | USD 20.6 | ▼ 0% |
| QLEIX | AQR Long-Short Equity Fund Clas | USD 21.97 | ▼ 0.59% |
| HMEZX | Nexpoint Merger Abritrage Fund | USD 19.85 | ▼ 0% |
| MBXIX | Catalyst/Millburn Hedge Strateg | USD 48.98 | ▲ 0% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 24, 2026 at 09:28 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt